A better understanding of the pathophysiologic mechanisms of diabetes has resulted in improved control of its local and systemic comorbidities. Further developments are needed, however, considering the growing number of diabetic patients and who are at risk for late-stage diabetic eye disease.
Research finds limited publications and dearth of information about side effects
Findings from the PERMEATE study used novel diagnostics to quantify response to intravitreal injections
Combination therapy benefits from laser in the mix for DME, other conditions
Sunir J. Garg, MD, discusses hypersonic vitrector settings in surgery in the exhibition hall at ASRS 2018 in Vancouver.
When used one week after injection, optical coherence tomography angiography can help clinicians determine how effective their treatment has been on neovascular membrane reperfusion.
Factoring in that patients require continual and constant monitoring, maintenance
Micoaneurysm turnover in the early stages of diabetic retinopathy predicts how much the disease will progress, according to researchers.
A phase II clinical trial evaluating suprachoroidal CLS-TA used with intravitreally administered aflibercept in patients with diabetic macular edema (DME) over a 6-month evaluation period-has met both primary and secondary endpoints of vision and anatomic improvement.
Study aims to identify methodology for least amount of variation, greatest test-retest reliability
